Scarlet Therapeutics is pioneering the use of engineered therapeutic red blood cells to produce life-saving new treatments. The company leverages proprietary red blood cell lines to make therapeutic products that are consistent and scalable.
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 11.05.2026 | Scarlet Therapeutics Raises £3.2m in Funding | Scarlet Therapeutics, a Bristol, UK-based biotechnology company developing red blood cell (RBC) therapies, raised £3.2M in funding The round was led by new investor Eos Advisory, with participation from existing investor SCVC, and new inves... |
| 23.05.2023 | Scarlet Therapeutics Raises Seed Financing | Scarlet Therapeutics, a Bristol, UK-based provider of red blood cell-based therapeutics, raised an undisclosed amount in Seed funding. The round saw participation from Science Creates Ventures and Meltwind. The company intends to use the fu... |
| - | Scarlet Therapeutics | “Scarlet Therapeutics” |